32 results
8-K
EX-99.1
IKT
Inhibikase Therapeutics Inc
30 Apr 24
Regulation FD Disclosure
8:17am
-001Pro for Treatment of Blood and Stomach Cancers and Cardiopulmonary Disease Inhibikase.com : IKT 17
IkT- 001Pro INNOVATION IkT-001Pro releases
424B3
t521u2i fy0y
4 Apr 23
Prospectus supplement
4:57pm
POS AM
51g3ph
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
PRE 14A
dm4sw6ixb94b0092 gjj
21 Apr 22
Preliminary proxy
4:33pm
8-K
EX-99.1
6dxr fwtd
20 Jan 22
Clinical Development of Therapies Intended to Reverse the Functional Loss in Parkinson’s and Related Disorders 1Q 2022 BUSINESS PRESENTATION IKT
4:10pm
8-K
EX-99.1
azvw86s6a7x3uva720g
19 Oct 21
Clinical Development of Therapies Intended to Reverse the Functional Loss in Parkinson’s and Related Disorders 4Q 2021 BUSINESS PRESENTATION IKT
5:03pm
8-K
EX-99.1
yel7xx
17 Aug 21
Regulation FD Disclosure
5:02pm
424B4
u8k6sj6cpu7cee
17 Jun 21
Prospectus supplement with pricing info
4:31pm
DRS
wwlig cpon
2 Jun 21
Draft registration statement
12:00am
8-K
EX-99.1
c3pwrq wv9b4p2ck
1 Jun 21
Regulation FD Disclosure
7:30am
DEF 14A
9ly ocyw88
30 Apr 21
Definitive proxy
5:20pm